Remimazolam for heart surgery anesthesia
Treatments studied
This trial tests a newer anesthetic drug, remimazolam, during heart surgery that uses a heart-lung machine. It aims to see if it is safe and works well for patients having this type of surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having planned (non-emergency) heart surgery that involves a heart-lung machine.
- You are between 18 and 65 years old.
- Your health status is classified as ASA grade I-III (meaning you are generally healthy or have mild to moderate disease).
- Your body mass index (BMI) is between 18 and 28.
- You have not had open chest heart surgery before.
- You have not taken sedative drugs like diazepam or similar in the last 3 months and are not allergic to certain anesthetics or their reversal drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares the anesthesia medicines remimazolam and propofol during major surgery to see how patients do afterward. It may help guide which anesthetic is safer or leads to better recovery in higher-risk patients.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
This study compares two different anesthesia combinations for chest surgeries to see which one works better for keeping you comfortable and stable during the operation. Participants will receive one of the two combinations, helping doctors learn which approach is safer and more effective.
This study tests whether a sedative called remimazolam can help protect the heart during surgery in older adults. If you are 65 or older and having a longer surgery with general anesthesia, this trial may be for you.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study tests a sedative called remimazolam to see how well it works and how safe it is for women having gynecologic surgery. It aims to find the best way to keep patients comfortable and stable during the procedure.
Hear when a new Anesthesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.